Larry Robbins Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 19 hours ago
Larry Robbins has an estimated net worth of at least $1.0 billion*, as of June 11, 2025. They own 8.2 million shares of CVS stock. They have sold 3.8 million shares of CVS stock since 2021, for an estimated $253.7 million.
Larry Robbins $CVS SEC Form 4 Insider Trading
Larry Robbins has filed a total of 6 insider trades in $CVS since 2021. Their most recent trade was a sale of 1.7 million shares, made on May 02, 2025. Their largest trade was a sale of 1.7 million shares, made on May 02, 2025. We estimate that they now own 8.2 million shares of $CVS, worth an estimated $774.9 million.
Insider Trading at $CVS
There have been a total of 50 insider trades reported at $CVS since 2021, with 61,751 shares purchased and 4.8 million shares sold. The most active insider traders in $CVS stock have been Prem S Shah, Daniel P Finke, and Alan Lotvin. The most recent trade was a purchase of 1,570 shares reported by GUY P SANSONE (None), made on Jun 05, 2025.
History of Insider Stock Trades by Larry Robbins
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CVS
|
Sale | 1.7 million | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 222,556 | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 373,776 | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 1.2 million | May 05, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 96,999 | May 05, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 150,000 | May 06, 2025 | May 6, 2025, 4:15 p.m. |
BFLY
|
Purchase | 244,774 | Aug 30, 2024 | Sept. 4, 2024, 4:34 p.m. |
|
BFLY
|
Purchase | 952,277 | Aug 28, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 294,673 | Aug 28, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 429,919 | Aug 29, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 500,000 | Mar 15, 2022 | March 14, 2022, 8 p.m. |
$CVS Executives and Stock Owners with Insider Trades
-
Prem S Shah, EVP and Co-President of Retail
-
Daniel P Finke, EVP/Pres, Health Care Benefits
-
Alan Lotvin, EVP&President-PharmacyServices
-
Thomas M Moriarty, EVP & General Counsel
-
Troyen A Brennan, EVP and Chief Medical Officer
-
James David Clark, SVP, Cont & Chief Acct Officer
-
Jonathan C Roberts, EVP & Chief Operating Officer
-
Karen S Lynch, President and CEO
-
Prem S Shah, EVP and Pres-Pharm, Consumer W
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.